Assignee
CELLGENTEK CO LTD
KR·2 granted patents·2 pending applications·0 citations·filing 2017–2021
Top patents by PatentIndex Score
4 records- 0144US11092610B2Biomarker SBP1 for early diagnosis of kidney diseases, and use thereofCELLGENTEK CO LTD·Filed 2017·Granted Aug 17, 2021·0 cites·3 claims
- 0236US2023150924A1Novel compound having cancer metastasis inhibitory activity, preparation method therefor, and pharmaceutical composition for inhibiting cancer metastasis and invasion or treating colorectal cancer, comprising compoundCELLGENTEK CO LTD·Filed 2020·Application pending·0 cites
- 0333US2023114854A1Chimeric antigen receptor targeting b-cell maturation antigen and use thereofCELLGENTEK CO LTD·Filed 2021·Application pending·0 cites
- 0422US11935666B2Apparatus for purifying nuclear reactor coolant from radioactive materials and adjusting coolant pHCELLGENTEK CO LTD·Filed 2017·Granted Mar 19, 2024·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when CELLGENTEK CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →